Original- und Übersichtsarbeiten im Jahr 2013

Jia WH, Zhang B, Matsuo K, Shin A, Xiang YB, Jee SH, Kim DH, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Delahanty RJ; Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO); Colon Cancer Family Registry (CCFR), Ji BT, Pan ZZ, Matsuda F, Gao YT, Oh JH, Ahn YO, Park EJ, Li HL, Park JW, Jo J, Jeong JY, Hosono S, Casey G, Peters U, Shu XO, Zeng YX, Zheng W (Investigators/Collaborators for the DACHS study in the GECCO Consortium: Brenner H, Butterbach K, Chang-Claude J, Hoffmeister M).
Genome-wide association analyses in east Asians identify new susceptibility loci for colorectal cancer.
Nature Genetics 2013; 45: 191-196.

Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H, and the GEKID Cancer Survival Working Group.
Survival of ovarian cancer patients in Germany in the early 21st century:a period analysis by age, histology, laterality and stage.
European Journal of Cancer Prevention 2013; 22: 59-67.

Schöttker B, Müller H, Rothenbacher D, Brenner H.
Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.
Diabetologia 2013; 56: 92-100.

Al Olama AA, Kote-Jarai Z, Schumacher FR, ..., Brenner H, …, Muller H, Rothenbacher D…; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The Australian Prostate Cancer Bioresource; The PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA.
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Human Molecular Genetics 2013; 22: 408-415.

Perna L, Felix J, Breitling LP, Haug U, Raum E, Burwinkel B, Schöttker B, Brenner H.
Genetic variations in the vitamin D binding protein and season specific serum levels of 25-hydroxyvitamin D among older adults.
Epidemiology 2013; 24: 104-109.

Brenner H, Altenhofen L, Tao S.
Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests.
Journal of Clinical Epidemiology 2013; 66: 202-208.

von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Cancela MC, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinàs JA, Faivre J, Wood LF, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Mádai S, Marinho J, Zakotnik JM, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Tuser MP, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Törnberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R.*
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication.
Endoscopy 2013; 45: 51-59.
* European Colorectal Cancer Screening Guidelines Working Group.

Koch L, Jansen L, Brenner H, Arndt V.
Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors-a systematic review of quantitative studies.
Psychooncology 2013; 22: 1-11.

Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group.
Survival of patients with oral cavity cancer in Germany.
PLoS One 2013; 8: e53415.

Verhoeven RHA, Gondos A, Janssen-Heijnen MLG, Saum KU, Brewster DH, Crocetti E, Rosso S, Hakulinen T, Aareleid T, Brenner H, and the EUNICE Survival Working Group.
Testicular cancer in Europe and the USA: Survival still rising among older patients.
Annals of Oncology 2013; 24: 508-513.

Stock C, Ihle P, Sieg A, Schubert I, Hoffmeister M, Brenner H.
Adverse events requiring hospitalization within 30 days after outpatient screening and non-screening colonoscopy.
Gastrointestinal Endoscopy 2013; 77: 419-429.

Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M.
Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups.
Haematologica 2013; 98: 222-229.

Müezzinler A, Zaineddin AK; Brenner H.
A systematic review of leukocyte telomere length and age in adults.
Ageing Research Reviews 2013; 12: 509-519.

Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Clinical Research in Cardiology 2013; 102: 193-202.

Brenner H, Jansen L.
Determinants and interpretation of death certificate only (DCO) proportions in the initial years of newly established cancer registries.
European Journal of Cancer 2013; 49: 931-937.

Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Øien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR, for the CKD Prognosis Consortium.* Do the associations of eGFR and albuminuria with mortality and renal failure differ by gender? A meta-analysis from a global consortium.
British Medical Journal 2013; 346:f324.
* Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Perna L, Butterbach K, Haug U, Schöttker B, Müller H, Arndt V, Holleczek B, Burwinkel B, Brenner H.
Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 437-442.

Gondos A, Döhler B, Brenner H,Opelz G.
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes.
Transplantation 2013; 95: 267-274.

Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.
Datenqualität oder Unterschiede in der onkologischen Versorgung? ― Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten.
Das Gesundheitswesen 2013; 75: 94-98.

Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H.
Strong associations of 25-hydroxyvitamin D levels with all-cause, cardiovascular, cancer and respiratory disease mortality in a large cohort study.
The American Journal of Clinical Nutrition 2013; 97: 782-793.

Jansen L, Hakulinen T, Brenner H.
Study populations for period analysis of cancer survival.
British Journal of Cancer 2013; 108: 699-707.

Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H.
Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2. A competing risk analysis in a large population-based cohort of older adults.
European Journal of Epidemiology 2013; 28: 267-275.

Verhoeven RHA, Janssen-Heijnen MLG, Saum K-U, Zanetti R, Caldarella A, Holleczek B, Brewster DH, Hakulinen T, Horenblas S, Brenner H, Gondos A, & the EUNICE Survival Working Group.
Population-based survival of penile cancer patients in Europe and the USA: No improvement since 1990.
European Journal of Cancer 2013; 49: 1414-1421.

Gaudet MM, Kuchenbaecker KB, Vijai J, ..., Brenner H, ...,Chenevix-Trench G, Antoniou AC, Offit K.
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
PLoS Genetics 2013; 9: e1003173.

Nickels S, Truong T, Hein R, ..., Brenner H, Müller H, Arndt V, ..., Garcia-Closas M, Milne RL, Chang-Claude J.
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.
PLoS Genetics 2013; 9: e1003284.

French JD, Ghoussaini M, Edwards SL,..., Brenner H, Müller H, Arndt V, ..., Chenevix-Trench G , Easton DF, Dunning AM.
Functional variants at the 11q13 risk locus for breast cancer regulate Cyclin D1 expression through long-range enhancers.
American Journal of Human Genetics 2013; 92: 489-503.

Holleczek B, Brenner H.
Model based period analysis of absolute and relative survival with R: Data preparation, model fitting and derivation of survival estimates.
Computer Methods and Programs in Biomedicine 2013; 110: 192-202.

Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, ..., Brenner H, Müller H, Arndt V, …, Garcia-Closas M, Pharoah PDP, Chenevix-Trench G, Dunning AM, Benitez J,Easton DF.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Nature Genetics 2013; 45: 353-361.

Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, ... , Brenner H, ..., Stegmaier C, ..., Müller H, Arndt V, ..., Easton DF, Berchuck A, Antoniou AC, Chenevix-Trench G, Dunning AM.
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics 2013; 45: 371-384.

Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, ..., Brenner H, …, Müller H, Rothenbacher D, …, The COGS–Cancer Research UKGWAS–ELLIPSE (part of GAME-ON) Initiative, The Australian Prostate Cancer Bioresource, The UKGenetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UKProtecT (Prostate testing for cancer and Treatment) Study Collaborators, The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF.
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Nature Genetics 2013; 45: 385-391.

Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, ... Brenner H, ..., Müller H, Arndt V,...,Pharoah PD, Vachon C, Easton DF, Haiman CA, Kraft P.
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Nature Genetics 2013; 45: 392-398.

Brenner H, Stock C, Hoffmeister.
Darmkrebs-Screening.
Therapeutische Umschau 2013; 70: 231-235.

Ulrich CM, Toriola AT, Siegel EM, Brenner H , Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady W on behalf of the ColoCare Consortium.
Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among
international colorectal cancer patients: a pilot study.
Journal of Nutritional Science 2013; 2: e9.

Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H & the GEKID Cancer Survival Working Group.
Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
European Journal of Cancer Prevention 2013; 22: 210-214.

Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert A-K.
Assisted reproductive techniques and the risk of the exstrophy-epispadias complex: A German case-control study.
The Journal of Urology 2013; 189: 1524-1529.

Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T,  Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia W-H, Kolonel LN, Kooperberg C, Küry S, LaCroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu X-O, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng Y-X, Zhang B, Zheng W, Hsu L, On behalf of Colon Cancer Family Registry (CCFR) and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO).
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-Analysis.
Gastroenterology 2013; 144: 799-807.

Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Kossler T, Pharoah P, Schafmayer C, Hampe J, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, von Holst S, Picelli S, Lindblom A, Jenkins MA, Hopper JL, Casey G, Duggan D, Newcomb PA, Abulí A, Bessa X, Ruiz-Ponte C, Castellví-Bel S, Niittymäki I, Tuupanen S, Karhu A, Aaltonen L, Zanke B, Hudson T, Gallinger S, Barclay E, Martin L, Gorman M, Carvajal-Carmona L, Walther A, Kerr D, Lubbe S, Broderick P, Chandler I, Pittman A, Penegar S, Campbell H, Tomlinson I, Houlston RS.
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals.
Gut 2013; 62: 871-881.

Shen H, Fridley BL, Song H, …, PRACTICAL Consortium*, …, Laird PW, Goode EL, Pearce CL.
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Nature Communications 2013;4:1628. Doi: 10.1038/ncomms2629.
*  Author on behalf of the ESTHER study: Brenner H.

Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H.
Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: Evidence from a large population-based study in Germany.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 821-826.

Ordóñez-Mena JM, Schöttker B, Haug U, Müller H, Köhrle J, Schomburg L, Holleczek B, Brenner H.
Serum 25-hydroxyvitamin D and cancer risk in older adults. Results from a large German prospective cohort study.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 905-916.

Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H;Gekid Cancer Survival Working Group.
Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.
Leukemia and Lymphoma 2013; 54: 979-985.

Tao S, Brenner H.
Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high quality colorectal cancer screening.
European Journal of Cancer Prevention 2013; 22: 305-310.

Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, Müller H, Brenner H.
Proinflammatory cytokines, adiponectin and increased risk of primary cardiovascular events in patients with diabetes and renal dysfunction: results from the ESTHER study.
Diabetes Care 2013; 36: 1703-1711.

Kote-Jarai Z, Saunders EJ, Leongamornlert DA, ..., Brenner H,..., The PRACTICAL Consortium, Easton DF, Eeles RA.
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Human Molecular Genetics 2013; 22: 2520-2528.

Schöttker B, Ball D, Gellert C, Brenner H.
Serum 25-hydroxyvitamin D levels and overall mortality.  A systematic review and meta-analysis of prospective cohort studies.
Ageing Research Reviews 2013; 12: 708-718.

Mons U, Nagelhout GE, Allwright S, Guignard R, van den Putte B, Willemsen MC, Fong GT, Brenner H, Pötschke-Langer M, Breitling LP.
Impact of national smoke-free legislation on home smoking bans – Findings from the International Tobacco Control (ITC) Policy Evaluation Project Europe Surveys.
Tobacco Control 2013; 22: e2-9.

Luo X, Stock C, Burwinkel B, Brenner H.
Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
PLoS One  2013; 8: e62880.

Gellert C, Schöttker B, Holleczek B, Stegmaier C, Müller H, Brenner H.
Using rate advancement periods for communicating the benefits of quitting to older smokers.
Tobacco Control 2013; 22: 227-230.

Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, and the GEKID Cancer Survival Working Group.
Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: A high resolution study by histology and age.
Cancer Epidemiology 2013; 37:492-497.

Brenner H, Altenhofen L, Stock C, Hoffmeister M.
Natural history of colorectal adenomas: Birth cohort analysis among 3.6 million participants of screening colonoscopy.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22: 1043-1051.

Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel E, Schirmacher P, Brenner H, Chang-Claude J.
Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β.
Cancer Research 2013; 73: 3306-3315.

Funke V, Lehmann J, Bickeböller M, Benner A, Tagscherer KE, Grund K, Pfeifer M, Herpel E, Schirmacher P, Chang-Claude J, Brenner H, Hoffmeister M, Roth W.
The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas.
Cancer Letters 2013; 335: 431-440.

Stock C, Hoffmeister M, Birkner B, Brenner H.
Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study.
Endoscopy 2013; 45: 537-546.

Jiao S, Hsu L, Bezieau S, Brenner H, Chan AT, Chang-Claude J, Le Marchand L, Lemire M, Newcomb PA, Slattery ML, Peters U.
SBERIA: Set Based gene EnviRonment InterAction test for rare and common variants in complex diseases.
Genetic Epidemiology 2013; 37: 452-464.

Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, and the GEKID Cancer Survival Working Group.
Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany.
PLoS One 2013; 8: e68077.

Stock C, Hoffmeister M, Birkner B, Brenner H.
Inter-physician variation in follow-up colonoscopies after screening colonoscopy.
PLoS One 2013; 8:e69312.

Koch L, Jansen L, Herrmann A, Stegmaier C, Holleczek B, Singer S, Brenner H, Arndt V.
Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study.
Acta Oncologica 2013: 52:1119-1128.

Brenner H, Chang-Claude J, Jansen L, Seiler CM, Hoffmeister M.
Colorectal cancers occurring after colonoscopy with polyp detection: Sites of polyps and sites of cancer.
International Journal of Cancer 2013; 133:1672-1679.

Gondos A, Hiripi E, Holleczek B, Luttmann S, Eberle A, Brenner H, and the GEKID Cancer Survival Working Group.
Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison.
International Journal of Cancer 2013; 133:2207-2215.

Brenner H, Tao S.
Superior diagnostic performance of fecal immunochemical tests for hemoglobin in a head-to-head comparison with guaiac based fecal occult blood test among 2235 participants of screening colonoscopy.
European Journal of Cancer 2013; 49:3049-3054.

Holleczek B, Jansen L, Brenner H.
Breast cancer survival in Germany: A population-based high resolution study from Saarland.
PLoS One 2013; 8:e70680.

Brenner H, Stock C, Hoffmeister M.
In the era of widespread endoscopy use randomized trials may strongly underestimate effects of colorectal cancer screening.
Journal of Clinical Epidemiology 2013; 66:1144-1150.

Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne K, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium*. Cystatin C versus creatinine for determining risk based on kidney function.
New England Journal of Medicine 2013; 369:932-943.
*Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Schöttker B, Koenig W.

Gellert C, Schöttker B, Müller H, Holleczek B, Brenner H.
Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults.
European Journal of Epidemiology 2013; 28:648-658.

Picelli S, Bermejo JL, Chang-Claude J, Hoffmeister M, Fernandez-Rozadilla C, Carracedo A, Castells A, Castellvi-Bel S, The EPICOLON Consortium, Naccarati A, Pardini B, Vodickova L, Müller H, Talseth-Palmer BA, Stibbard G, Peterlongo P, Nici C, Veneroni S, Li L, Casey G, Tenesa A, Farrington SM, Tomlinson I, Moreno V, van Wezel T, Wijnen J, Dunlop M, Radice P, Scott RJ, Vodicka P, Ruiz-Ponte C, Brenner H, Buch S, Völzke H, Hampe J, Schafmayer C, Lindblom A.
Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility.
PLoS One 2013; 8:e72091.

Yu OH, Foulkes WD, Dastani Z, Martin RM, Eeles R, PRACTICAL Consortium*, CRUK GWAS Investigators, Richards JB.
An assessment of the shared allelic architecture between type II diabetes and prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention 2013; 22:1473-1475.
*Author on behalf of the ESTHER study: Brenner H.

Rothenbacher D, Hoffmann MM, Breitling LP, Rajman I, Koenig W, Brenner H.
Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events. Results of a long-term follow-up study in routine clinical care.
BMC Cardiovascular Disorders 2013; 13:61.

Tao S, Seiler CM, Ronellenfitsch U, Brenner H.
Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer.
Acta Oncologica 2013; 52:1667-1675.

Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi M, Brenner H, Müller H, Harris C, Duell E, Andrew A, McLaughlin J, Schwartz AG, Wenzlaff A, Stucker I.
Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO).
British Journal of Cancer 2013; 109:1954-1964.

Mons U, Schöttker B, Müller H, Kliegel M, Brenner H.
History of lifetime smoking, smoking cessation and cognitive function in the elderly population.
European Journal of Epidemiology 2013; 28:823-831.

Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock g, Qiao Q, Lewington s, Di Angelantonio E, van der Hoorn S, Lawes CMM, Ali MK, Mozaffarian D, Ezzati M, Global Burdon of Metabolic Risk Factors of Chronic Diseases Collaborating Group, Asia-Pacific Cohort Studies Collaboration (APCSC), Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE), Emerging risk Factor Collaboration (ERFC)*, Prospective Studies Collaboration (PSC).
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis.
PloS One 2013; 8:e65174.
*Authors on behalf of the ESTHER study: Brenner H, Schöttker B, Müller H, Rothenbacher D.

Schöttker B, Brenner H, Koenig W, Müller H, Rothenbacher D.
Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany.
Preventive Medicine 2013; 57:596-600.

Mons U, Raum E, Krämer HU, Rüter G, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H.
Effectiveness of a supportive telephone counseling intervention in type 2 diabetes patients: randomized controlled study.
PLoS One 2013; 8:e77954.

Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, Bézieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti CV, Duggan D, Fuchs CS, Gallinger S, Giovannucci E, Harrison TA, Hayes R, Hazra A, Henderson B, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Küry S, Le Marchand L, Lemire M, Ma J, Manson JE, Nan H, Newcomb PA, Ng K, Potter JD, Schoen RE, Schumacher F, Seminara D, Slattery ML, Wactawski-Wende J, White E, Wu K, Zanke BW, Kraft P, Peters U, Chan AT.
Genetic predictors of circulating 25-Hydroxyvitamin D and risk of colorectal cancer.
Cancer Epidemiology 2013; 22:2037-2046.

Gatta G, Rossi S, Foschi R, Trama A, Marcos-Gragera R, Pastore G, Peris-Bonet R, Stiller C, Capocaccia R, and the EUROCARE Working Group*
Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.
Haematologica 2013; 98:744-752.
*Authors from Germany: Brenner H, Kaatsch P, Holleczek B.

Yin L, Ordonez-Mena JM, Chen T, Schöttker B, Arndt V, Brenner H.
Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.
Preventive Medicine 2013; 57:753-764.

Holmes MV, Simon T, Exeter HJ, ..., Breitling LP, Brenner H, ..., Hingorani AD, Marc S, Sabatine MS, Mallat Z, Casas JP, Philippa J, Talmud PJ.
Secretory phospholipase A2-IIA and cardiovascular disease: a Mendelian randomized study.
Journal of the American College of Cardiology 2013; 62:1966-1976.

Perna L, Hoffmeister M, Schöttker B, Arndt V, Haug U, Burwinkel B, Ordonez-Mena JM, Brenner H.
Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality.
Cancer Epidemiology 2013; 37:905-907.

Perna L, Schöttker B, Holleczek B, Brenner H.
Serum 25-hydroxyvitamin D and incidence of fatal and non-fatal cardiovascular events: a prospective study with repeated measurements.
Journal of Clinical Endocrinology & Metabolism 2013; 98:4908-4915.

Stock C, Holleczek B, Hoffmeister M, Stolz T, Stegmaier C, Brenner H.
Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance.
PLoS One 2013; 8:e82676.

Hoffmeister M, Bläker H, Kloor M, Roth W, Toth C, Herpel E, Frank B, Schirmacher P, Chang-Claude J, Brenner H.
Body mass index and microsatellite instability in colorectal cancer: a population-based study.
Cancer Epidemiology, Biomarkers & Prevention 2013;22:2303-2311.

Silbernagel G, Schöttker B, Scharnagel H, Kleber ME, Grammer TB, Ritsch A, Appelbaum S, Mons U, Holleczek B, Goliasch G, Niessner A, Boehm BO, Schnabel RB, Brenner H, Blankenberg S, Landmesser U, März W.
High density lipoprotein cholesterol, coronary artery disease and cardiovascular mortality.
European Heart Journal 2013; 34:3563-3571.

Chang CM, Chia VM, Gunter MJ, Zanetti KA, Ryan BM, Goodman JE, Harris CC, Weissfeld J, Huang WY, Chanock S, Yeager M, Hayes RB, Berndt SI; Genetics and Epidemiology of colorectal Cancer Consortium (GECCO); (Investgators/Collaborators for the DACHS study in the GECCO Consortium: Brenner H, Chang-Claude J).
Innate immunity gene polymorphisms and the risk of colorectal neoplasia.
Carcinogenesis 2013; 34:2512-2520.

Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, ..., Brenner H, Müller H, Arndt V, Stegmaier C, ..., Poder BA, Dunning AM, Easton DF.
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
The American Journal of Human Genetics 2013; 93:1046-1060.

Dworschak GC, Draaken M, Marcelis C, de Blaauw I, Pfundt R, van Rooij IA, Bartels E, Hilger a, Jenetzky E, Schmiedeke E, Grasshoff-Derr S, Schmidt D, Märzheuser S, Hosie S, Weih S, Holland-Cunz S, Palta M, Leonhardt J, Schäfer M, Kujath C, Rissmann A, Nöthen MM, Zwink N, Ludwig M, Reutter H.
De novo 13q deletions in two patients with mild anorectal malformations as part of VATER/VACTERL and VATER/CACTERL-like association and analysis of EFNB2 in patients with anorectal malformations.
American Journal of Medical Genetics 2013; 161A:3035-3041.

Choinitzki V, Zwink N, Bartels F, Baudisch F, Boemers TM, Hölscher A, Turial S, Bachour H, Heydweiller A, Kurz R, Bartmann P, Pauly M Brokmeier U, Leutner A, Nöthen MM, Schuhmacher J, jenetzky E, Reutter H.
Second study on the recurrence risk of isolated esophageal atresia with or without trachea-esophageal fisstula among first-degree relatives: No evidence for increased risk of recurrence of EA/TEF or for malformations of the VATER/VACTERL association spectrum.
Birth Defects Research (Part A): Clinical Molecular Teratology 2013; 97:786-791.

de Blaauw I, Wijers CH, Schmiedeke E, Holland-Cunz S, Gamba P, Marcelis CL, Reutter H, Aminoff D, Schipper M, Schwarzer N, Grasshoff-Derr S, Midrio P, Jenetzky E, van Rooij IA.
First results of a European multi-center registry of patients with anorectal malformations.
Journal of Pediatric Surgery 2013; 48:2530-2535.

Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, and the GEKID Cancer Survival Working Group.A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.
Cancer Medicine 2013; 2:718-724.

Pulte D, Barnes B, Jansen L, Eisemann N, Emrich K, Gondos A, Henschel S, Hollezcek B, Kraywinkel K, Brenner H "for the GEKID Cancer Survival Workgroup".Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.
Journal of Hematology & Oncology 2013; 6:70.

Sansone G, Fong GT, Hall PA, Guignard R, Beck F, Mons U, Pötschke-Langer M, Yong HH, Thompson ME, Omar M, Jiang Y.
Time perspective as a predictor of smoking status: fndings from the International Tobacco Control (ITC) Surveys in Scotland, France, Germany, China and Malaysia.
BMC Public Health 2013; 13:346.

Levy DT, Blackman K, Currie LM, Mons U.
Germany SimSmoke: the effect of tobacco control policies on future smoking prevalence and smoking-attributable deaths in Germany.
Nicotine & Tobacco Research 2013; 15:465-473.

Matsushita K, Ballew SH, Astor BC, de Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen C-P, Woodward M, Coresh J, and for the CKD Prognosis Consortium*.
Cohort profile: The Chronic Kidney Disease Prognosis Consortium.
International Journal of Epidemiology 2013, 42:1660-1668.
*Authors on behalf of the ESTHER study: Rothenbacher D, Brenner H, Müller H, Schöttker B.

Bünger S, Klempt-Giessing K, Toner V, Kelly M, FitzGerald SP, Brenner H, von Eggeling F, Habermann JK.
A novel multiplex-protein array for serum diagnostics of colorectal cancer: impact of pre-analytical storage conditions.
Biopreservation and Biobanking 2013; 11:379-386.




 

Blättern

nach oben